Enter our Boardroom for New Perspectives on Rx Drug Advertising and Promotion
ACI is delighted to present our inaugural Think Tank on Rx Drug Advertising and Promotion. Come and join our exclusive boardroom in which advertising and promotion thought leaders from companies such as Allergan, Bayer, Bristol-Myers Squibb, Eisai, and Sanofi will participate in discussions of real-life experiences with the CFL Guidance and social media promotion.
Together, in our think tank, we’ll work through hypotheticals to find solutions to many of our everyday advertising and promotional challenges. We’ll learn to embrace new media while complying with FDA regulation.
Finally, we’ll close our boardroom with an interactive case study and hypothetical which will assist you in developing a compliant and successful Rx pharmaceutical advertising and promotional campaign.
THIS EXCLUSIVE THINK TANK WILL BE LED BY:
Moulakshi (Mou) Roychowdhury
Executive Director, Regulatory Affairs – Advertising & Labeling
Counsel & Associate Director, CRA
Associate Director, Regulatory Affairs
Advertising and Promotion
VP & Head, NA General Med.
& Established Products /US Ad-Promo
Dara Katcher Levy
Hyman, Phelps & McNamara, P.C.
Commercial Regulatory Affairs,
Neurology Business Unit
Denise Sánchez Palomo
Commercial Regulatory Affairs
Marc J. Scheineson
Alston & Bird LLP (Washington, D.C.)
JOIN US AS WE ANALYZE, DEBATE, AND ENGAGE IN CASE STUDIES ON:
The CFL guidance and understanding what it means to promote within the label
The risks and benefits of conforming campaigns to social media platforms
New advertising and promotion controversies including promotional campaigns for controlled substances and the communication of pricing information
Fostering greater and more effective collaboration between the legal, compliance, and regulatory teams
This Think Tank has been designed in collaboration with industry authorities and offers unique opportunities to participate with your peers and interact with advertising and promotion doyens.
Sign up now as seating in the boardroom is limited.
- In-House counsel and business executives responsible for advertising, promotion and labeling
- Law firm attorneys with FDA practices with a focus on advertising, promotion, and labeling